Financial Enhancement Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-17
Closed -$4K 280
2020
Q3
$4K Hold
17
﹤0.01% 189
2020
Q2
$4K Hold
17
﹤0.01% 196
2020
Q1
$3K Hold
17
﹤0.01% 229
2019
Q4
$4K Hold
17
﹤0.01% 216
2019
Q3
$3K Hold
17
﹤0.01% 240
2019
Q2
$3K Hold
17
﹤0.01% 234
2019
Q1
$3K Buy
+17
New +$3.25K ﹤0.01% 251

Other funds holding AMGN

Financial Enhancement Group's AMGN Position: Q4 2020 in Review

Financial Enhancement Group sold out of Amgen (AMGN) in Q4 2020, closing a stake of 17 shares — an estimated $4K sold.

Financial Enhancement Group first reported a position in AMGN in Q1 2019 and held it in 7 quarters. The position peaked at $4K in Q3 2020. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q4 2020.

  • Financial Enhancement Group reported no remaining Amgen position as of Q4 2020 after selling out during the quarter.
  • Financial Enhancement Group sold 17 Amgen shares in Q4 2020, an estimated $4K.
  • Financial Enhancement Group first reported a position in Amgen in Q1 2019 and held it in 7 quarters.
  • Financial Enhancement Group's Amgen position peaked at $4K in Q3 2020.
  • 2,218 funds tracked by Wall St. Rank held Amgen as of Q4 2020.

Based on Financial Enhancement Group's 13F filing for Q4 2020, filed 10 Feb 2021.